Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
| ▸ | RXRG | P48443 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
| ▸ | PTPRC | P08575 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24147884 | 0.89 | RXRA (0.35) | DAOKDM4ETDP1CYP11B1CYP11B2 | |
| SCHEMBL24149394 | 0.87 | CYP11B1 (0.39) | DAOKDM4ETDP1CYP11B1CYP11B2 | |
| SCHEMBL24369891 | 0.87 | KDM4E (0.33) | DAOKDM4ETDP1CYP11B1CYP11B2 | |
| SCHEMBL26426214 | 0.82 | KDM4E (0.36) | KDM4ETDP1CYP11B1CYP11B2ENPP2 | |
| SCHEMBL25826338 | 0.81 | RXRA (0.33) | DAOKDM4ETDP1RXRARXRB | |
| SCHEMBL25788389 | 0.79 | KIF11 (0.30) | KIF11 | |
| SCHEMBL24147891 | 0.79 | RXRA (0.38) | KDM4ETDP1RXRARXRBRXRG | |
| SCHEMBL1039622 | 0.78 | KDM4E (0.42) | KDM4ETDP1CYP11B1CYP11B2ENPP2 | |
| SCHEMBL24149758 | 0.78 | CYP11B1 (0.36) | KDM4ETDP1CYP11B1CYP11B2RXRA | |
| SCHEMBL24147888 | 0.76 | KDM4E (0.38) | KDM4ETDP1CYP11B1CYP11B2RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024126528-A1 | ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A COMPOUND OF FORMULA (II), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE | NOVALED GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| WO-2023232967-A1 | ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A COMPOUND OF FORMULA (II), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE | NOVALED GMBH (DE) | 2023-12-07 | — | — | WO | disclosed |
| WO-2023148215-A1 | 3,6-BIS(CYANOMETHYLIDENE)CYCLOHEXA-1,4-DIENE COMPOUNDS AND THEIR USE IN ORGANIC ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2023-08-10 | — | — | WO | disclosed |
| US-20230247901-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
| US-20230247900-A1 | Organic Compound of Formula (I) for Use in Organic Electronic Devices, an Organic Electronic Device Comprising a Compound of Formula (I) and a Display Device Comprising the Organic Electronic Device | NOVALED GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
| US-20230247900-A1 | Organic Compound of Formula (I) for Use in Organic Electronic Devices, an Organic Electronic Device Comprising a Compound of Formula (I) and a Display Device Comprising the Organic Electronic Device | NOVALED GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
| US-20230240137-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-07-27 | — | — | US | disclosed |
| US-20230240138-A1 | Organic Electronic Device and Display Device Comprising the Organic Electronic Device as Well as a Composition for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-07-27 | — | — | US | disclosed |
| WO-2023139444-A1 | LIGHT-EMITTING DEVICE | 株式会社半導体エネルギー研究所 | 2023-07-27 | — | — | WO | disclosed |
| US-20230232712-A1 | Organic Electronic Device and Display Device Comprising the Organic Electronic Device as Well as a Composition for Use in Organic Electronic Devices | NOVALED GMBH (DE) | 2023-07-20 | — | — | US | disclosed |
| WO-2022263531-A1 | ACTIVE-MATRIX OLED DISPLAY | NOVALED GMBH (DE) | 2022-12-22 | — | — | WO | disclosed |
| EP-4106027-A1 | ACTIVE-MATRIX OLED DISPLAY | Novaled GmbH (DE) | 2022-12-21 | — | — | EP | disclosed |
| EP-3989305-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (1), DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS COMPOUNDS OF FORMULA (1) FOR USE IN ORGANIC ELECTRONIC DEVICES | Novaled GmbH (DE) | 2022-04-27 | — | — | EP | disclosed |
| EP-3989303-A1 | ORGANIC COMPOUND OF FORMULA (I) FOR USE IN ORGANIC ELECTRONIC DEVICES, AN ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE | Novaled GmbH (DE) | 2022-04-27 | — | — | EP | disclosed |
| EP-3989301-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (1), DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS COMPOUNDS OF FORMULA (1) FOR USE IN ORGANIC ELECTRONIC DEVICES | Novaled GmbH (DE) | 2022-04-27 | — | — | EP | disclosed |
| WO-2021259785-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (I), DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS COMPOUNDS OF FORMULA (I) FOR USE IN ORGANIC ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2021-12-30 | — | — | WO | disclosed |
| WO-2021259793-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS A COMPOSITION FOR USE IN ORGANIC ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2021-12-30 | — | — | WO | disclosed |
| WO-2021259788-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS A COMPOSITION FOR USE IN ORGANIC ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2021-12-30 | — | — | WO | disclosed |
| WO-2021259782-A2 | ORGANIC COMPOUND OF FORMULA (I) FOR USE IN ORGANIC ELECTRONIC DEVICES, AN ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE | NOVALED GMBH (DE) | 2021-12-30 | — | — | WO | disclosed |
| WO-2021259784-A2 | ORGANIC ELECTRONIC DEVICE COMPRISING A COMPOUND OF FORMULA (I), DISPLAY DEVICE COMPRISING THE ORGANIC ELECTRONIC DEVICE AS WELL AS COMPOUNDS OF FORMULA (I) FOR USE IN ORGANIC ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2021-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240137-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | AOX1, CYP2C19, CYP2C9 | DAO 869/4885KDM4E 2544/4885TDP1 3073/4885 |
| US-20230247900-A1 | Organic Compound of Formula (I) for Use in Organic Electronic Devices, an Organic Electronic Device Comprising a Compound of Formula (I) and a Display Device Comprising the Organic Electronic Device | AOX1, CYP2C19, CYP2C9 | DAO 603/4885KDM4E 2865/4885TDP1 2911/4885 |
| US-20230247901-A1 | Organic Electronic Device Comprising a Compound of Formula (I), Display Device Comprising the Organic Electronic Device as Well as Compounds of Formula (I) for Use in Organic Electronic Devices | AOX1, CYP2C19, CYP2C9 | DAO 738/4885KDM4E 2492/4885TDP1 2861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.